In this free webinar, gain insights into pursuing grassroots community activation ahead of clinical trial recruitment to build trust with minority and underrepresented communities. Attendees will learn creative ways to weave authenticity and the patient voice into every aspect of a clinical trial to improve recruitment and retention. The featured speakers will discuss how minority patients want to be communicated with in relation to a clinical trial. The speakers will also share considerations to help maintain compliance with the Food and Drug Omnibus Reform Act of 2022 (FDORA) and the recent US Food and Drug Administration (FDA) draft guidance on diversity action plans.

TORONTO, Aug. 15, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar that addresses how the pharmaceutical industry can enhance trial accessibility and representation by encouraging clinical trial diversity.

Over the last few years, it has become clear that the pharmaceutical industry still has a lot of work to do to make clinical trials more inclusive, diverse and accessible to all patients. While Food and Drug Omnibus Reform Act of 2022 (FDORA) and the recent US Food and Drug Administration (FDA) draft guidance on diversity plans is a start, it is critical that pharmaceutical and biotech companies start thinking early about diversity initiatives — even before study recruitment begins!

In this webinar, the speakers bring together a diverse panel, including a patient advocate, community organizer and representatives from two top 10 pharmaceutical companies, to discuss the importance of activating local community leaders to build trust ahead of a specific clinical study. The panel will share their unique perspectives and outline two case studies, demonstrating how study teams practically implemented diversity, equity and inclusion (DE&I) initiatives to boost recruitment and retention.

The first case study details a unique grassroots, community activation approach that recruited African American women into their studies related to lupus. The second case study will showcase a video series that demonstrates the power of elevating diverse patient voices to build trust and inspire clinical trial participation.

Register for this webinar today to learn about successful community engagement and how the inclusion of different patient narratives is helping improve clinical trial diversity.

Join LaToya Bolds-Johnson, Breast Cancer Survivor, Patient Advocate; Kevin Aniskovich, CEO, Jumo Health; Tony Wafford, President & CEO, I Choose Life Foundation; Gwenn Oakes, Director, Global Trial Optimization, Merck; and Senior Manager, Patient Engagement & Recruitment Lead, Bristol Myers Squibb, for the live webinar on Monday, September 9, 2024, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Why Authenticity and Patient Voice Are Critical When Driving Clinical Trial Diversity.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com

View original content to download multimedia:https://www.prweb.com/releases/why-authenticity-and-patient-voice-are-critical-when-driving-clinical-trial-diversity-upcoming-webinar-hosted-by-xtalks-302223749.html

SOURCE Xtalks